Implantable Medical Devices Market Report 2026

Implantable Medical Devices Market Overview

• Implantable Medical Devices market size has reached to $109.97 billion in 2025 • Expected to grow to $148.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.2% • Growth Driver: Increasing Demand For Minimally Invasive Surgical Procedures Fueling The Growth Of The Market Due To Enhanced Recovery And Reduced Complications • Market Trend: Bioelectric Medicine Enables Personalized And Minimally Invasive Therapies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Implantable Medical Devices Market?

Implantable medical devices are medical instruments or apparatuses that are surgically placed inside the human body to monitor, support, or replace a biological function. These devices are designed to remain inside the body for extended periods, either temporarily or permanently, to help diagnose, treat, or manage various health conditions. The main product types of implantable medical devices include cardiovascular implants, orthopedic implants, ophthalmology implants, dental implants, cochlear implants, microchip implants, and others. Cardiovascular implants are medical devices surgically placed in the body to support, repair, or replace parts of the heart or blood vessels, such as stents, pacemakers, or artificial valves. These can be made using various biomaterials such as ceramic, metallic, polymers, and natural materials, serving end users such as hospitals, ambulatory surgical centers, multi-specialty centers, clinics, and others.

What Is The Implantable Medical Devices Market Growth Forecast?

The implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $148.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to development of bioresorbable and smart implants, rising demand for customized and patient-specific implants, growth in minimally invasive surgical techniques, expansion of cochlear and neural interface implants, integration of ai and digital monitoring technologies. Major trends in the forecast period include rising adoption of cardiovascular and orthopedic implants, increasing demand for minimally invasive implant procedures, growth in personalized and customizable implants, expansion of neurostimulator and drug delivery implant usage, enhanced regulatory compliance and safety standards.

Global Implantable Medical Devices Market Segmentation

1) By Product Type: Cardiovascular Implants, Orthopedic Implants, Ophthalmology Implants, Dental Implants, Cochlear Implants, Microchip Implants, Other Product Types 2) By Biomaterial: Ceramic, Metallic, Polymers, Natural 3) By End Use: Hospitals, Ambulatory Surgical Centers, Multi-Specialty Centers, Clinics, Other End Uses Subsegments: 1) By Cardiovascular Implants: Pacemakers, Implantable Cardioverter Defibrillators, Stents, Heart Valves, Cardiac Resynchronization Therapy Devices 2) By Orthopedic Implants: Hip Implants, Knee Implants, Spinal Implants, Shoulder Implants, Trauma Implants 3) By Ophthalmology Implants: Intraocular Lenses, Glaucoma Drainage Implants, Corneal Implants, Retinal Implants 4) By Dental Implants: Endosteal Implants, Subperiosteal Implants, Zygomatic Implants, Mini Dental Implants 5) By Cochlear Implants: Unilateral Cochlear Implants, Bilateral Cochlear Implants 6) By Microchip Implants: Radiofrequency Identification Implants, Biosensor Microchips, Neural Interface Microchips 7) By Other Product Types: Neurostimulators, Contraceptive Implants, Drug Delivery Implants, Breast Implants, Penile Implants

What Is The Driver Of The Implantable Medical Devices Market?

The increasing demand for minimally invasive surgical procedures is expected to propel the growth of the implantable medical devices market in the future. Minimally invasive procedures refer to medical interventions performed through small incisions or openings, reducing patient trauma and recovery time. The demand for minimally invasive surgical procedures is increasing due to their ability to offer shorter recovery times, reduced risks of complications, less pain, and smaller scars, making them more appealing to patients seeking quicker and safer treatment options. Implantable medical devices enhance minimally invasive surgical procedures by enabling targeted treatment delivery and real-time monitoring. They support faster recovery, reduce the risk of complications, and improve long-term patient outcomes through personalized, precise interventions. For instance, in November 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, marking a 7% increase from 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive surgical procedures drives the growth of the implantable medical devices industry.

Key Players In The Global Implantable Medical Devices Market

Major companies operating in the implantable medical devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Alcon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Terumo Medical Corporation, Smith & Nephew plc, W. L. Gore & Associates Inc., Edwards Lifesciences Corporation, Dentsply Sirona Inc., Demant A S, Institut Straumann AG, Biotronik SE & Co. KG, Integra LifeSciences Holdings Corporation, Globus Medical Inc., LivaNova Public Limited Company, MicroPort Scientific Corporation, B. Braun Melsungen Aktiengesellschaft, Cochlear Limited

Global Implantable Medical Devices Market Trends and Insights

Major companies operating in the implantable medical devices market are focusing on developing technologically advanced products and getting approvals, such as bioelectric medicine, to enhance treatment efficacy, reduce side effects, and offer personalized, minimally invasive therapeutic solutions. Bioelectric medicine is a field that uses electrical signals to diagnose, treat, or stimulate the body's nervous system to improve health and manage diseases. For instance, in July 2023, Boston Scientific Corporation, a US-based biotechnology company, received U.S. Food and Drug Administration (FDA) approval for the Vercise Neural Navigator 5 Software, which, when used as part of the Vercise Genus deep brain stimulation (DBS) systems, can provide clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson’s disease or essential tremor. It provides enhanced flexibility in programming, allowing tailored treatment plans that can adapt to each patient’s unique symptoms and needs.

What Are Latest Mergers And Acquisitions In The Implantable Medical Devices Market?

In November 2024, Boston Scientific Corporation, a US-based medical device company, acquired Axonics Inc. for approximately $3.7 billion. With this acquisition, Boston Scientific aims to expand its urology and pelvic health portfolio by integrating Axonics’ innovative sacral neuromodulation systems and Bulkamid urethral bulking agent, offering enhanced treatment options for patients with urinary and bowel dysfunction. Axonics Inc. is a US-based medical technology company specializing in implantable devices for treating urinary and bowel dysfunction.

Regional Outlook

North America was the largest region in the implantable medical devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Implantable Medical Devices Market?

The implantable medical devices market consists of sales of diagnostic implants, therapeutic implants, monitoring implants, and mechanical implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.